Case Study #2
Read the Merck and River Blindness case beginning on page 63 of Chapter. After reading the case, respond to the following questions in essay format:
1. Why was Merck hesitant about developing a human version of Invermectin?
2. What would be the benefits and cost of developing a human version of Invermectin?
3. Why did Dr. P. Roy Vagelos and his team decide to develop a human version of Invermectin?
Prepare your responses in a Word document that is in essay format. Do not simply list and answer the questions.
Essay should be a minimum of 2 pages in length (APA format).
At least two references are required. Please be sure to cite and reference in APA.
https://platform.virdocs.com/r/s/0/doc/556618/sp/34057362/mi/129902939/?cfi=%2F4%2F8
https://platform.virdocs.com/r/s/0/doc/556618/sp/34057363/mi/129902935